Awareness of Inflammatory Bowel Disease in Bahrain: A Survey-Based Study
Hawra Alalwan, Abdulla Yateem, Abdulrahman Saleh, Mahmood Alawainati, Ghadeer Alasfoor, Razan Saleh, Turki AlAmeel

TL;DR
This study finds low awareness of inflammatory bowel disease in Bahrain, highlighting the need for public education to improve early diagnosis.
Contribution
The paper provides the first survey-based assessment of IBD awareness in Bahrain, identifying key demographic factors influencing knowledge levels.
Findings
Over half of participants had never heard of Crohn’s disease, and only 25% correctly identified affected organs.
Only 35.7% had heard of ulcerative colitis, with 38.6% correctly identifying the involved organ.
Higher education, healthcare occupation, and family history of IBD were linked to better knowledge (P < 0.001).
Abstract
Background: Limited awareness of inflammatory bowel disease (IBD) can lead to diagnostic delays and increased risk of complications. Although awareness levels may vary across demographic and educational groups, there is a notable paucity of research investigating IBD awareness in Bahrain. To address this gap, the present study aims to evaluate the awareness levels of IBD among the Bahraini population. Methodology: A cross-sectional survey was conducted at 10 primary healthcare centers in Bahrain using a multistage sampling technique. Adult individuals without a prior history of IBD were invited to complete validated questionnaires. Each correct response received a score of one, with a maximum score of three. Results: A total of 516 individuals completed the questionnaire. Two hundred seventy-six (53.5%) participants had never heard of Crohn’s disease (CD), and only 130 (25.2%)…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Variables |
| |
| Sex | Male | 286 (55.4) |
| Female | 230 (44.6) | |
| Age (mean ± SD) | 37.99 ± 13.87 | |
| Age groups | <30 years | 163 (31.6) |
| 30-39 years | 136 (26.4) | |
| 40-49 years | 107 (20.7) | |
| 50 and above | 110 (21.3) | |
| Nationality | Bahraini | 430 (83.3) |
| Non-Bahraini | 86 (16.7) | |
| Educational level | No formal education | 25 (4.8) |
| Primary school | 14 (2.7) | |
| Middle school | 47 (9.1) | |
| Secondary school | 207 (40.1) | |
| College level | 190 (36.8) | |
| Post-graduate studies | 33 (6.4) | |
| Employment status | Employed | 228 (44.2) |
| Unemployed | 158 (30.6) | |
| Retired | 72 (14) | |
| Student | 58 (11.2) | |
| Are you currently working in the healthcare field? | Yes | 27 (5.2) |
| No | 489 (94.8) | |
| Do you have a family history of inflammatory bowel disease (IBD)? | Yes | 17 (3.3) |
| No | 470 (91.1) | |
| I do not know | 29 (5.6) | |
| Have you ever experienced hematochezia? | Yes | 50 (9.7) |
| No | 429 (83.1) | |
| I do not know | 37 (7.2) | |
| Have you undergone any previous surgeries involving the small intestine or colon? | Yes | 15 (2.9) |
| No | 496 (96.1) | |
| I do not know | 5 (1) | |
| Have you ever undergone an endoscopy (gastroscopy or colonoscopy)? | Yes | 103 (20) |
| No | 409 (79.3) | |
| I do not know | 4 (0.8) | |
| Statement |
| |
| Have you read about Crohn’s disease (CD)/dealt with a CD patient? | Did not hear or read about CD | 276 (53.5) |
| I might have heard about CD somewhere | 75 (14.5) | |
| I got some information regarding this disease, and I read about it | 42 (8.1) | |
| Personally, I dealt with this disease, or one of my family members did | 16 (3.1) | |
| I do not know | 107 (20.7) | |
| CD can mainly affect: | Head/heart | 1 (0.2) |
| Liver | 2 (0.4) | |
| It is an infectious disease | 15 (2.9) | |
| Small/Large intestine | 130 (25.2) | |
| I do not know | 368 (71.3) | |
| Is there a medical therapy for CD? | Yes | 71 (13.8) |
| No | 24 (4.7) | |
| I do not know | 421 (81.6) | |
| Have you heard, read about Ulcerative colitis (UC), or dealt with a UC disease patient? | Did not hear or read about UC | 184 (35.7) |
| I might have heard about UC somewhere | 133 (25.8) | |
| I got some information regarding this disease, and I read about it | 56 (10.9) | |
| Personally, I dealt with this disease, or one of my family members did | 20 (3.9) | |
| I do not know | 123 (23.8) | |
| UC can mainly affect: | Head/heart | 2 (0.4) |
| Liver | 7 (1.4) | |
| It is an infectious disease | 6 (1.2) | |
| Large intestine | 199 (38.6) | |
| I do not know | 302 (58.5) | |
| Is there a medical therapy for UC? | Yes | 108 (20.9) |
| No | 26 (5) | |
| I do not know | 382 (74) | |
| Sociodemographic and baseline characteristics | Combined (mean ± SD) |
| Test value | |
| Sex | Male | 1.76 ± 1.82 | 0.102* | 1.637 |
| Female | 1.5 ± 1.73 | |||
| Nationality | Bahraini | 1.69 ± 1.76 | 0.242* | 1.172 |
| Non-Bahraini | 1.44 ± 1.89 | |||
| Age groups | <30 years | 1.99 ± 1.71 | 0.006** | 4.168 |
| 30-39 years | 1.68 ± 1.92 | |||
| 40-49 years | 1.50 ± 1.67 | |||
| 50 years and above | 1.25 ± 1.75 | |||
| Educational level | No formal education | 0.12 ± 0.44 | <0.001** | 27.025 |
| Primary school | 0.43 ± 1.16 | |||
| Middle school | 0.51 ± 1 | |||
| Secondary school | 1.34 ± 1.44 | |||
| College level | 2.23 ± 1.84 | |||
| Post-graduate studies | 3.55 ± 2.2 | |||
| Employment status | Employed | 1.93 ± 1.87 | <0.001** | 6.350 |
| Unemployed | 1.24 ± 1.59 | |||
| Retired | 1.35 ± 1.76 | |||
| Student | 2 ± 1.69 | |||
| Are you currently working in the healthcare field? | Yes | 3.19 ± 2.08 | <0.001* | 4.702 |
| No | 1.56 ± 1.73 | |||
| Do you have a family history of IBD? | Yes | 2.88 ± 2.26 | <0.003** | 5.526 |
| No | 1.57 ± 1.73 | |||
| I do not know | 2.1 ± 1.97 | |||
| Have you ever experienced hematochezia (the passage of fresh blood through the anus)? | Yes | 1.68 ± 1.68 | 0.976** | 0.025 |
| No | 1.65 ± 1.78 | |||
| I do not know | 1.59 ± 1.92 | |||
| Have you undergone any previous surgeries involving the small intestine or colon? | Yes | 1.4 ± 1.64 | 0.356** | 1.034 |
| No | 1.67 ± 1.79 | |||
| I do not know | 0.6 ± 0.89 | |||
| Have you ever undergone an endoscopy (Gastroscopy or colonoscopy)? | Yes | 1.68 ± 1.82 | 0.756** | 0.281 |
| No | 1.65 ± 1.78 | |||
| I do not know | 1 ± 1.41 | |||
| In your opinion, is there sufficient awareness about IBD? | Yes | 1.78 ± 1.94 | <0.001** | 10.367 |
| No | 1.99 ± 1.85 | |||
| I do not know | 1.26 ± 1.59 | |||
| Do you believe that there should be awareness campaigns about IBD? | Yes | 1.81 ± 1.81 | <0.001** | 11.346 |
| No | 0.7 ± 1.89 | |||
| I do not know | 0.86 ± 1.34 |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInflammatory Bowel Disease · Microscopic Colitis · Autoimmune and Inflammatory Disorders
Introduction
Inflammatory bowel disease (IBD) is a chronic systemic inflammatory disorder with a predilection to the gastrointestinal tract [1]. It is comprised of Crohn's disease (CD) and ulcerative colitis (UC). Although IBD mainly affects the intestinal tract, it may also involve other organ systems in the body, such as the skin, eyes, and joints [2]. Several factors contribute to the complex pathogenesis of IBD, including host genetics, dysregulated immune responses, intestinal microbiota, and environmental factors [3].
The global burden of IBD is increasing worldwide as the prevalence of IBD has increased over the years in both industrialized and newly industrialized nations, including the Arab world [4-5]. A meta-analysis of 16 articles assessing the clinical epidemiology in seven Arab countries revealed a growing incidence of IBD in the Arab world. The incidence was estimated to be 2.33 and 1.64 per 100,000 persons per year for UC and CD, respectively [6]. In Bahrain, the average number of reported IBD cases has increased from three to 14 cases per year in the period between 1984 and 2014 [7].
The diagnosis of IBD can be difficult. This, in addition to a lack of awareness about the disease, may result in a delay in the diagnosis. Data from the Swiss IBD cohort study has estimated the median diagnostic delay in CD to be nine (3-24) months. The length of diagnostic delay was associated with an increased risk of bowel stenosis, intestinal and perianal fistulas, and need for surgery [8]. In UC, diagnostic delay was estimated to be three (interquartile range (IQR) 2-10) months, with more patients experiencing extraintestinal manifestations (EIM) when the diagnosis was delayed [9].
Previous studies have investigated the awareness of IBD worldwide and have reported an overall low level of awareness among the general population in different community sectors. Young age, female gender, and higher level of education were associated with better awareness [10-12]. To date, there are no published studies assessing the awareness of IBD in the general population in Bahrain, therefore, the purpose of this study was to assess the public awareness of IBD and the variables affecting it, such as level of education and having a family member affected by IBD.
Materials and methods
Study design and population
This was a cross-sectional study conducted on adults attending primary healthcare centers in Bahrain using a multistage sampling technique. Two primary healthcare centers were selected randomly from each of the five health regions in Bahrain. Patients attending these selected centers were invited to participate in the study. Those with a personal history of IBD were excluded. The study protocol was reviewed and approved by the Research Committee of Primary Health Care in the Kingdom of Bahrain on May 5, 2024 (Approval No. PHCRC/TOR/0012/2024).
Research tool and data collection process
Data were collected using a self-administered online questionnaire through Google Forms. The questionnaire was administered by asking participants to scan a barcode to answer the questions under the direct supervision of a member of the research team.
The research tool was a questionnaire that assessed public awareness of IBD. The questionnaire, which was previously used in an Austrian study, was translated into Arabic according to the World Health Organization (WHO) criteria by a group of researchers in Saudi Arabia [11-12]. It consisted of two parts: the first part of the questionnaire gathered basic demographic data and independent variables, including personal or family history of IBD, a history of experiencing specific symptoms, and any prior endoscopic procedures or surgeries involving the colon or small bowel. These independent variables were used to help identify factors associated with IBD awareness and examine potential correlations with the results obtained from the awareness assessment. The second part of the questionnaire included six questions about general knowledge of UC and CD. Each question was assigned a score of one for the appropriate answer, with the possibility of having more than one appropriate answer in the first question. The maximum score was 3. Moreover, the respondents were asked whether they believed there was adequate awareness of IBD or if there should be more public awareness on the matter (Appendices A-C).
Pilot study
A pilot study was conducted with 18 participants to evaluate the reliability of the questionnaire. Reliability was assessed by calculating Cronbach's alpha coefficient, which was estimated to be 0.739, indicating acceptable internal consistency and demonstrating that the questionnaire was reliable for use in the main study.
Data analysis plan
Data were analyzed using SPSS (version 25.0; IBM Corp, Armonk, NY). Data were presented as frequencies and percentages for categorical variables, and as means and standard deviations for continuous variables. t-test and analysis of variance (ANOVA) were used to compare the means of the continuous variables. For all analyses, P-values of less than 0.05 were considered significant.
Results
From September to October 2024, a total of 569 individuals were asked to complete the questionnaire; 53 of them refused to participate, resulting in a response rate of 90.69%.
Out of the 516 respondents, 286 (55.4%) were male. The average age of the participants was 37.9 years, and 163 (31.6%) were under 30 years old. The majority of the respondents were Bahraini nationals (430, 83.3%). Additionally, 228 participants (44.2%) were employed, 27 (5.2%) of whom were healthcare workers. Regarding educational level, 207 participants (40.8%) completed secondary school and 190 (36.8%) were college graduates, while only 25 (4.8%) were illiterate. Moreover, only 17 respondents (3.3%) had a family history of IBD, and 50 (9.7%) had experienced hematochezia before. Furthermore, 496 participants (96.1%) reported they had never undergone any bowel or colonic surgeries, and 409 (79.3%) had never undergone any endoscopic procedure. Sociodemographic and baseline characteristics of the participants are shown in Table 1.
Regarding awareness of the CD, 276 participants (53.5%) had never heard of or read about CD, while only 42 (8.1%) had some information about the disease. Furthermore, only 130 respondents (25.2%) knew that CD affects the intestine, and 421 (81.6%) were unaware that there is medical treatment for CD. Regarding UC, 184 participants (36%) had not heard of or read about it, while 133 (25.8%) might have read or heard about it. In addition, 199 respondents (38.6%) correctly identified that UC affects the large bowel and 382 (74%) were unaware that treatment for UC exists. Results are shown in Table 2.
The respondents’ combined average awareness score for IBD was 1.65 ± 1.78 (mean ± SD), with higher awareness levels toward UC compared to CD (1.00 ± 1.12 and 0.65 ± 0.97, respectively).
When comparing IBD knowledge among different variables, a significant difference was observed across educational levels. Participants holding college and postgraduate degrees scored significantly higher than those with lower educational attainment (2.23 ± 1.84, 3.55 ± 2.2, respectively; *P *< 0.001). Moreover, employees and students demonstrated higher average scores (1.93 ± 1.87, 2 ± 1.69, respectively) compared to unemployed and retired respondents (1.24 ± 1.59, 1.35 ± 1.76, respectively) (P < 0.001). Notably, healthcare workers had higher average scores (3.19 ± 2.08) than employees in other fields (P < 0.001) and participants with a family history of IBD also had higher scores (2.88 ± 2.26) compared to participants without a family history of IBD (1.57 ± 1.73; *P *< 0.003).
There was no significant difference in awareness levels between males and females, as both had approximately similar scores (1.76 ± 1.82, 1.5 ± 1.73, respectively, *P *= 0.102). This was also noted among Bahraini and non-Bahraini nationals (1.69 ± 1.76, 1.44 ± 1.89, respectively, *P *= 0.242). In addition, there was no significant difference in awareness scores for participants who had experienced hematochezia, undergone intestinal surgeries, or undergone gastroscopy or colonoscopy, compared to those who had not, as shown in Table 3.
When asked about the sufficiency of IBD awareness, 246 participants (47.5%) reported that awareness of IBD is insufficient, and 427 (82.9%) believed that there should be more public awareness campaigns for IBD.
Discussion
This study demonstrated an overall low level of awareness of IBD among the general population in Bahrain. Factors such as working in the healthcare field, a higher level of education, and a family history of IBD were associated with better awareness levels.
A low level of awareness was similarly observed in two studies done in Saudi Arabia. Alqahtani et al. revealed a low level of IBD knowledge among the Saudi general population, and Meeralam et al. concluded that the level of awareness was unacceptable [10-11]. On the other hand, Aldakhil et al. did a study on 648 participants in the Alqassim area; their study found a good level of awareness, with more than half of the participants exhibiting good awareness of various aspects of IBD, like symptoms, risk factors, and complications [13]. Reasons for these differences in awareness might include geographical variations, in addition to the fact that most of the study participants were young and educated.
Gender did not pose a significant difference in awareness in our study (*P *= 0.102). However, in the study by Meeralam et al., females had higher average scores in awareness than males [11]. Additionally, Alkully et al. assessed the adequacy of IBD knowledge in 473 Saudi participants and found that females had a significantly more adequate level of knowledge compared to men [14]. Generally, women engage more in health-seeking behaviours and are more open to communicating about their health than men [15-16].
When comparing knowledge of IBD across different academic levels, there was a significant association between the knowledge level of IBD and respondents' educational level (*P *< 0.001). Specifically, respondents with higher educational achievements had higher awareness compared to their counterparts. This observation was seen in many other studies, and this highlights the importance of targeting the lower educational groups [10-11,13].
As expected, healthcare workers exhibited better awareness compared to non-healthcare workers (*P *< 0.001). This aligns with the study by Aldakhil et al. which looked into the level of awareness among participants who had a professional medical background compared to other professionals and found that the former had significantly higher levels of awareness about IBD [13]. In addition, a study by Eid et al. investigated where participants are getting their information about IBD and found that about half cited healthcare professionals as their primary source, followed by awareness campaigns [17].
Family history of IBD is one of the strongest risk factors for developing IBD [18], and the present study demonstrated that participants who have a family history of IBD scored significantly higher than their counterparts (*P *< 0.003). In the study by Aldakhil et al., most participants were aware that family history of IBD is a risk factor for developing IBD; additionally, these participants exhibited better awareness of IBD [13].
When assessing factors that could be associated with better awareness levels, we found that experiencing symptoms like hematochezia or having any endoscopic procedure or intestinal surgery were not significantly associated with better awareness of IBD.
This study has several strengths. It is the first nationwide study assessing the awareness of IBD in Bahrain, and it was supported by a large sample size that included both nationals and expats. In addition, participants were asked to participate in the questionnaire in person with access to instructions when needed. However, our study had limitations; the participants of the study were only recruited from primary healthcare centers, and the results may not reflect individuals who do not engage with public health services. Larger-scale future studies are needed to assess the generalizability of the results and to further identify factors affecting the awareness of IBD in the remaining patient population.
Conclusions
Although this study had limitations, our findings suggest that the low level of awareness surrounding IBD continues to challenge patients, physicians, and the healthcare system. Lower educational levels and non-medical professions are associated with even lower levels of awareness. Addressing this gap through education and awareness tailored to certain patient populations is critical to improve the outcome and quality of life for individuals living with this condition.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Morphology of inflammatory bowel diseases (IBD)Cesk Patol Fabián O KamaradováK 2737582022 https://pubmed.ncbi.nlm.nih.gov/35387455/35387455 · pubmed ↗
- 2Ecco guidelines on extraintestinal manifestations in inflammatory bowel disease J Crohns Colitis Gordon H Burisch J Ellul P 1371820243735185010.1093/ecco-jcc/jjad 108 · doi ↗ · pubmed ↗
- 3A comprehensive review and update on the pathogenesis of inflammatory bowel disease J Immunol Res Guan Q 7247238201920193188630810.1155/2019/7247238 PMC 6914932 · doi ↗ · pubmed ↗
- 4The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet Gastroenterol Hepatol 1730520203164897110.1016/S 2468-1253(19)30333-4PMC 7026709 · doi ↗ · pubmed ↗
- 5Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Lancet Ng SC Shi HY Hamidi N 2769277823201710.1016/S 0140-6736(17)32448-029050646 · doi ↗ · pubmed ↗
- 6Incidence, prevalence, and clinical epidemiology of inflammatory bowel disease in the Arab world: a systematic review and meta-analysis Inflamm Intest Dis Mosli M Alawadhi S Hasan F Abou Rached A Sanai F Danese S 123131620213472264210.1159/000518003 PMC 8527904 · doi ↗ · pubmed ↗
- 7Inflammatory bowel disease in Bahrain: single-center experience Clin Exp Gastroenterol Abdulla M Al Saeed M Fardan RH Alalwan HF Ali Almosawi ZS Almahroos AF Al Qamish J 1331451020172876571310.2147/CEG.S 127909 PMC 5524702 · doi ↗ · pubmed ↗
- 8Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate Am J Gastroenterol Schoepfer AM Dehlavi MA Fournier N 1744175310820132397895310.1038/ajg.2013.248 · doi ↗ · pubmed ↗
